- Home
- MLSS vs ATNM Comparison
MLSS vs ATNM Comparison
Compare MLSS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- ATNM
- Stock Information
- Founded
- MLSS 1989
- ATNM 2000
- Country
- MLSS United States
- ATNM United States
- Employees
- MLSS N/A
- ATNM N/A
- Industry
- MLSS Industrial Specialties
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- ATNM Health Care
- Exchange
- MLSS Nasdaq
- ATNM Nasdaq
- Market Cap
- MLSS 42.4M
- ATNM 50.2M
- IPO Year
- MLSS 1995
- ATNM N/A
- Fundamental
- Price
- MLSS $0.31
- ATNM $1.41
- Analyst Decision
- MLSS Buy
- ATNM Strong Buy
- Analyst Count
- MLSS 1
- ATNM 1
- Target Price
- MLSS $1.00
- ATNM $4.00
- AVG Volume (30 Days)
- MLSS 3.2M
- ATNM 211.4K
- Earning Date
- MLSS 11-13-2025
- ATNM 11-14-2025
- Dividend Yield
- MLSS N/A
- ATNM N/A
- EPS Growth
- MLSS N/A
- ATNM N/A
- EPS
- MLSS N/A
- ATNM N/A
- Revenue
- MLSS $8,929,517.00
- ATNM $90,000.00
- Revenue This Year
- MLSS $16.06
- ATNM N/A
- Revenue Next Year
- MLSS $14.73
- ATNM N/A
- P/E Ratio
- MLSS N/A
- ATNM N/A
- Revenue Growth
- MLSS 0.59
- ATNM 11.11
- 52 Week Low
- MLSS $0.28
- ATNM $1.03
- 52 Week High
- MLSS $1.39
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- MLSS 34.23
- ATNM 54.09
- Support Level
- MLSS $0.28
- ATNM $1.25
- Resistance Level
- MLSS $0.32
- ATNM $1.42
- Average True Range (ATR)
- MLSS 0.04
- ATNM 0.10
- MACD
- MLSS -0.00
- ATNM 0.02
- Stochastic Oscillator
- MLSS 20.58
- ATNM 59.46
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.